openPR Logo
Press release

The Future is Now and It's Terrifying: Sci-Fi Thriller 'Transhuman' Warns of Technology's Dark Side

04-26-2024 11:38 PM CET | Associations & Organizations

Press release from: ABNewswire

The Future is Now and It's Terrifying: Sci-Fi Thriller

Conspiracies, cutting-edge tech, and a heroine's relentless pursuit of truth collide in the series finale
Author Isabella MacLeod brings her captivating series to a breathtaking close with the release of "Transhuman," the thrilling conclusion that takes readers on an unforgettable journey through the realms of science fiction and suspense.

"Transhuman" is the final installment in MacLeod's gripping series, which began with "Metamorphosis" in 2015 and continued with "Nano" in 2019. In this climactic conclusion, readers are reunited with protagonist Miranda MacLeod as she faces her most daunting challenges yet.

Miranda has overcome devastating setbacks in her personal and professional life, including the dissolution of her marriage and the trauma of a mysterious illness known as Morgellons, which was revealed to be a result of advanced nanotechnology poisoning. Through her harrowing experiences, Miranda discovers that she was unwittingly enrolled in a Non-Consensual Human Bio Experimentation program, pushing her to the brink of physical, psychological, and spiritual endurance.

Supported by her love, Gabriel, Miranda embarks on a perilous journey to uncover the truth behind her ordeal. As she navigates through a world of direct energy weapons and secret black op technologies, Miranda forms unlikely alliances with private investigators, former spies, and clandestine operatives. Alongside Dr. Christianson, the scientist inadvertently involved in her plight, Miranda battles to survive being 'Targeted for Death' while unraveling the sinister reality of the program that threatens humanity itself.

"Transhuman" is a masterfully crafted tale of resilience, intrigue, and revelation that will keep readers on the edge of their seats until the final page. Isabella MacLeod's vivid storytelling and meticulous attention to detail make "Transhuman" a must-read for fans of science fiction and suspense alike.

The book is available on Amazon in the Hardcover format, consisting of 148 pages written in the English language.

To learn more about Isabella MacLeod, please visit here http://isabellamacleod.com/

To purchase the book on Amazon, please visit here https://www.amazon.com/Transhuman-Continuation-Metamorphosis-Final-Chapter-ebook/dp/B0C329M4ZJ/?_encoding=UTF8&pd_rd_w=M59Hk&content-id=amzn1.sym.cf86ec3a-68a6-43e9-8115-04171136930a&pf_rd_p=cf86ec3a-68a6-43e9-8115-04171136930a&pf_rd_r=145-9073242-5460460&pd_rd_wg=lSuJU&pd_rd_r=957a1f3e-0da6-40de-9ae2-f00b9ab40d02&ref_=aufs_ap_sc_dsk

Media Contact
Company Name: Isabella MacLeod
Contact Person: Media Relations
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=the-future-is-now-and-its-terrifying-scifi-thriller-transhuman-warns-of-technologys-dark-side]
Country: United States
Website: http://www.isabellamacleod.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The Future is Now and It's Terrifying: Sci-Fi Thriller 'Transhuman' Warns of Technology's Dark Side here

News-ID: 3478064 • Views:

More Releases from ABNewswire

Synovial Sarcoma Pipeline and Clinical Trials Assessment 2024: FDA Approvals, Therapies and Key Companies involved by DelveInsight | EpiZyme, Merck & Co, Immunocore, Johnson & Johnson, Karyopharma
Synovial Sarcoma Pipeline and Clinical Trials Assessment 2024: FDA Approvals, Th …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Synovial Sarcoma pipeline constitutes 15+ key companies continuously working towards developing 20+ Synovial Sarcoma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Synovial Sarcoma Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed
AKPKD Pipeline Drugs Analysis Report (2024 Updates): FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight | Galapagos NV, Reata Pharma, Kadmon Pharma, Sanofi, Anakuria Therapeutics
AKPKD Pipeline Drugs Analysis Report (2024 Updates): FDA Approvals, Clinical Tri …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Autosomal Dominant Polycystic Kidney Disease pipeline constitutes 12+ key companies continuously working towards developing 12+ Autosomal Dominant Polycystic Kidney Disease treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Autosomal Dominant Polycystic Kidney Disease Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to
High-Grade Glioma Pipeline Assessment, 2024 Updates | In-depth Insights into the Emerging Drugs, Latest FDA, EMA, and PMDA Approvals, Clinical Trials, and Treatment Outlook | Chimerix, BioMimetix
High-Grade Glioma Pipeline Assessment, 2024 Updates | In-depth Insights into the …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, High-Grade Glioma pipeline constitutes 150+ key companies continuously working towards developing 150+ High-Grade Glioma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The High-Grade Glioma Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed
Neuroblastoma Pipeline Drugs Analysis Report, 2024: FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight | Aum Bio, NanoPharma, Athenex, Actuate Therapeutics
Neuroblastoma Pipeline Drugs Analysis Report, 2024: FDA Approvals, Clinical Tria …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Neuroblastoma pipeline constitutes 35+ key companies continuously working towards developing 35+ Neuroblastoma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Neuroblastoma Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the

All 5 Releases


More Releases for MacLeod

Career Transition and Outplacement Market to Deliver Prominent Growth and Striki …
The latest report on the Career Transition and Outplacement Market provides a comprehensive overview of the industry's important characteristics, including production, market growth rate, industry share, consumption value and volume, demand for specific types of products and services, and more. The publication focuses on providing a competitive advantage to industry newcomers and those who aim to enter the market in the next years. It offers information on the most recent
Corporate Assessment Services Market Is Booming Worldwide | AON, Chandler Macleo …
Global Corporate Assessment Services Market by Player, Region, Type, Application and Sales Channel is latest research study released by HTF MI evaluating the market risk side analysis, highlighting opportunities and leveraged with strategic and tactical decision-making support (2021-2030). The report provides information on market trends and development, growth drivers, technologies, and the changing investment structure of the Global Corporate Assessment Services Market. Some of the key players profiled in the
Bankruptcy Trade Claim Market Global and Regional Analysis and Forecast 2027 | D …
Trade Claim means any Unsecured Claim arising from or with respect to the sale of goods or rendition of services prior to the Petition Date in the ordinary course of the applicable Debtor's business, including any Claim of an employee that is not a Priority Claim. Disallowed Claim means a Claim or any portion thereof, that is not listed on the Debtors' Schedules, or is listed therein as contingent, unliquidated,
Bankruptcy Trade Claim Market | Global and Regional Analysis and Forecast 2027 | …
Bankruptcy Trade Claim Market describes an in-depth evaluation and Covid19 Outbreak study on the present and future state of the Bankruptcy Trade Claim market across the globe, including valuable facts and figures. Bankruptcy Trade Claim Market provides information regarding the emerging opportunities in the market & the market drivers, trends & upcoming technologies that will boost these growth trends. The report provides a comprehensive overview including Definitions, Scope, Application, Production
12 Days 12 Christmas Songs by Dana MacLeod
Dana MacLeod an up and coming singer/songwriter from Canada and the newest artist to sign with M n N Record is taking time out from recording her new album “Mirrors”, which is due out next year, to spread some much needed Christmas cheer. “It’s been a very difficult year for all of us, the music and entertainment industry have been hit particularly hard. I wanted to spread a bit of festive
Online Corporate Assessment Services Market Insights 2027 - Worldwide Industry L …
Online Corporate Assessment Services market report comprises of data that can be quite essential when it comes to dominate the market or making a mark in the market as a new emergent. The statistics are represented in graphical format in this Online Corporate Assessment Services market report for a clear understanding on facts and figures. The report provides you the insights which help you have a more precise understanding of